(Title of the Thesis)*

Total Page:16

File Type:pdf, Size:1020Kb

(Title of the Thesis)* THE PHYSIOLOGICAL ACTIONS OF ADIPONECTIN IN CENTRAL AUTONOMIC NUCLEI: IMPLICATIONS FOR THE INTEGRATIVE CONTROL OF ENERGY HOMEOSTASIS by Ted Donald Hoyda A thesis submitted to the Department of Physiology In conformity with the requirements for the degree of Doctor of Philosophy Queen‟s University Kingston, Ontario, Canada (September, 2009) Copyright © Ted Donald Hoyda, 2009 ABSTRACT Adiponectin regulates feeding behavior, energy expenditure and autonomic function through the activation of two receptors present in nuclei throughout the central nervous system, however much remains unknown about the mechanisms mediating these effects. Here I investigate the actions of adiponectin in autonomic centers of the hypothalamus (the paraventricular nucleus) and brainstem (the nucleus of the solitary tract) through examining molecular, electrical, hormonal and physiological consequences of peptidergic signalling. RT-PCR and in situ hybridization experiments demonstrate the presence of AdipoR1 and AdipoR2 mRNA in the paraventricular nucleus. Investigation of the electrical consequences following receptor activation in the paraventricular nucleus indicates that magnocellular-oxytocin cells are homogeneously inhibited while magnocellular-vasopressin neurons display mixed responses. Single cell RT-PCR analysis shows oxytocin neurons express both receptors while vasopressin neurons express either both receptors or one receptor. Co-expressing oxytocin and vasopressin neurons express neither receptor and are not affected by adiponectin. Median eminence projecting corticotropin releasing hormone neurons, brainstem projecting oxytocin neurons, and thyrotropin releasing hormone neurons are all depolarized by adiponectin. Plasma adrenocorticotropin hormone concentration is increased following intracerebroventricular injections of adiponectin. I demonstrate that the nucleus of the solitary tract, the primary cardiovascular regulation site of the medulla, expresses mRNA for AdipoR1 and AdipoR2 and mediates adiponectin induced hypotension. Adiponectin has electrical effects on a majority of medial solitary tract neurons and depolarizes those expressing mRNA for the hypotensive neuropeptide Y, revealing a central mechanism to modulate blood pressure. ii Finally, I show that adiponectin controls paraventricular nucleus neuron excitability by either inhibiting a tetraethyl ammonium-sensitive potassium current thereby depolarizing neurons or activating a glibenclamide-sensitive voltage independent potassium current hyperpolarizing neurons. Therefore, adiponectin differentially modulates potassium current to confer its central effects. These results are the first to show the physiological and electrical actions of adiponectin on individual neurons in blood brain barrier protected central autonomic nuclei. This thesis provides a framework for how adiponectin acts centrally to coordinate whole body energy homeostasis and feeding behavior in the rat. iii CO-AUTHORSHIP Chapter 2: RT-PCR experiments were performed with assistance from Dr. Mark Fry. The in situ hybridization study was performed by Dr. Rexford S. Ahima. In all other instances, including conception, design, collection and analysis were performed by Ted D. Hoyda. The manuscript was written by Ted Hoyda with the assistance of Dr. Alastair V. Ferguson. Chapter 3: Single Cell RT-PCR experiments were performed with assistance from Ms. Christie Hopf, while icv injections of adiponectin followed by plasma assays for ACTH and TSH were performed by Dr. Willis K. Samson. Design, collection and analysis of all other experiments were performed by Ted D. Hoyda. The manuscript was composed by Ted D. Hoyda with assistance from Dr. Alastair V. Ferguson. Chapter 4: Experiments were designed by Ted D. Hoyda. Microinjection of adiponectin in the nucleus of the solitary tract and analysis of blood pressure and heart rate was performed by Ms. Pauline M. Smith. Single cell RT-PCR experiments were performed with Ms. Christie Hopf‟s assistance. All other data was collected and analyzed by Ted D. Hoyda. The manuscript was written by Ted D. Hoyda with the assistance of Dr. Alastair V. Ferguson. Chapter 5: All experiments were designed, collected and analyzed by Ted D. Hoyda. The manuscript was written by Ted Hoyda with assistance from Dr. Alastair V. Ferguson. iv ACKNOWLEDGEMENTS First and foremost I acknowledge and thank the „Boss‟, Al Ferguson for the important contributions you made to my development as a student and human-being. On my first „serious‟ day as a graduate student I remember you sharing those important words; “the data is what the data is”, a truth which has served me well throughout my studies and will for the rest of my life. Thanks for taking a chance and allowing me to pursue an important step in my education (and for that I will never count a „foot wedge‟ on your scorecard, even if we are playing with Dean). For all of you who I have had the pleasure of sharing a lab with past and present, thank you for making this seem rarely like work and more a time just spent with friends. Tequila Barbara, Jungle Cat Jenny, „Dish‟, Christie (phone: “h., o., p., f..for..”), Nancy („Drew‟ ie solving the mystery of the coed-softball double play), Matty (July 23, 2009, „Fran‟ time: 9:15, just for posterity‟s sake), Fry Guy and Spud (Friday afternoon/night? I know where to find you), PMS (is that Peter Gabriel singing?) and Dr. Price (Jebus…where to begin?) thanks for the great times and interesting conversations. Thanks to Coach G and Coach B who reveal me an important outlet with which to take out my (occasional) PhD frustrations, usually to the point where I just can‟t remember them anymore (hypoglycemia). A deep thanks to my parents, who show me the importance of being a „finisher‟, as they are themselves. Thanks to ES, FD and LT for helping me through the last couple of months. To the one who knows me best, I send to you my deepest thanks, appreciation and respect. I know I‟m complicated and difficult; often teetering on the brink in the whimsical fantasyland that I live in, but when I get lost Laura, I know I only have to look for your beacon, start walking and I‟ll be home. v TABLE OF CONTENTS ABSTRACT ------------------------------------------------------------------------------------------------- ii CO-AUTHORSHIP --------------------------------------------------------------------------------------- iv ACKNOWLEDGEMENTS ------------------------------------------------------------------------------- v TABLE OF CONTENTS -------------------------------------------------------------------------------------- vi LIST OF FIGURES --------------------------------------------------------------------------------------------- ix LIST OF TABLES ----------------------------------------------------------------------------------------------- xi LIST OF ABBREVIATIONS -------------------------------------------------------------------------------- xii Chapter 1 : GENERAL INTRODUCTION ----------------------------------------------------------- 1 ADIPOSE TISSUE AS AN ENDOCRINE ORGAN -------------------------------------------------- 3 ADIPONECTIN: STRUCTURE AND FUNCTION -------------------------------------------------- 3 The generation of adiponectin knockout mice 5 The insulin sensitizing effects of adiponectin 7 ADIPONECTIN RECEPTORS: DISCOVERY ---------------------------------------------------- 8 The generation of adiponectin receptor knockout mice 12 SIGNAL TRANSDUCTION PATHWAYS OF THE ADIPONECTIN RECEPTORS ---- 13 ADIPONECTIN ACTIONS IN THE CENTRAL NERVOUS SYSTEM --------------------- 14 Effects on sympathetic nervous system activity and autonomic function 16 THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS -------------------- 17 Neural inputs to the PVN 18 Projections of the PVN 19 Neuronal Subtypes in the PVN: Morphological and Electrical Characteristics 20 Type 1: Magnocellular Neurons 20 Type II: Pre-autonomic Parvocellular neurons 21 Type III: Parvocellular Neuroendocrine 22 Neurochemical cell phenotypes in the PVN 23 Oxytocin 23 Vasopressin 24 vi Thyrotropin releasing hormone 26 Corticotropin releasing hormone 27 THE NUCLEUS OF THE SOLITARY TRACT -------------------------------------------------- 28 Afferent projections to the NTS 28 Efferent projections of the NTS 29 Electrophysiology of the NTS 29 Neurochemical expression in the NTS 30 Neuropeptide Y 31 STATEMENT OF PROBLEM ----------------------------------------------------------------------- 33 Chapter 2 : ADIPONECTIN SELECTIVELY INHIBITS OXYTOCIN NEURONS OF THE PARAVENCTRICULAR NUCLEUS OF THE HYPOTHALAMUS -------------------- 34 ABSTRACT 35 INTRODUCTION 37 MATERIALS AND METHODS 38 RESULTS 44 DISCUSSION 51 ACKNOWLEDGEMENTS 58 Chapter 3 : ADIPONECTIN DEPOLARIZES PARVOCELLULAR PARAVENTRICULAR NUCLEUS NEURONS CONTROLLING NEUROENDOCRINE AND AUTONOMIC FUNCTION ---------------------------------------------------------------------- 59 ABSTRACT 60 INTRODUCTION 61 MATERIALS AND METHODS 62 RESULTS 68 DISCUSSION 77 ACKNOWLEDGEMENTS 81 Chapter 4 : ADIPONECTIN ACTS IN THE NUCLEUS OF THE SOLITARY TRACT TO DECREASE BLOOD PRESSURE BY MODULATING THE EXCITABILITY OF NEUROPEPTIDE Y NEURONS ----------------------------------------------------------------------- 82 ABSTRACT 83 INTRODUCTION 85 MATERIALS AND METHODS 86 RESULTS 93 DISCUSSION 99 ACKNOWLEDGEMENTS 103 Chapter 5 : IONIC MECHANISMS RESPONSIBLE FOR ADIPONECTIN INDUCED CHANGES TO THE EXCITABILITY OF PARVOCELLULAR PVN NEURONS ------- 104 vii ABSTRACT 105 INTRODUCTION 106 MATERIALS AND METHODS 108 RESULTS 111 DISCUSSION
Recommended publications
  • Multifaceted Physiological Roles of Adiponectin in Inflammation And
    International Journal of Molecular Sciences Review Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases Hyung Muk Choi 1, Hari Madhuri Doss 1,2 and Kyoung Soo Kim 1,2,* 1 Department of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul 02447, Korea; [email protected] (H.M.C.); [email protected] (H.M.D.) 2 East-West Bone & Joint Disease Research Institute, Kyung Hee University Hospital at Gangdong, Gandong-gu, Seoul 02447, Korea * Correspondence: [email protected]; Tel.: +82-2-961-9619 Received: 3 January 2020; Accepted: 10 February 2020; Published: 12 February 2020 Abstract: Adiponectin is the richest adipokine in human plasma, and it is mainly secreted from white adipose tissue. Adiponectin circulates in blood as high-molecular, middle-molecular, and low-molecular weight isoforms. Numerous studies have demonstrated its insulin-sensitizing, anti-atherogenic, and anti-inflammatory effects. Additionally, decreased serum levels of adiponectin is associated with chronic inflammation of metabolic disorders including Type 2 diabetes, obesity, and atherosclerosis. However, recent studies showed that adiponectin could have pro-inflammatory roles in patients with autoimmune diseases. In particular, its high serum level was positively associated with inflammation severity and pathological progression in rheumatoid arthritis, chronic kidney disease, and inflammatory bowel disease. Thus, adiponectin seems to have both pro-inflammatory and anti-inflammatory effects. This indirectly indicates that adiponectin has different physiological roles according to an isoform and effector tissue. Knowledge on the specific functions of isoforms would help develop potential anti-inflammatory therapeutics to target specific adiponectin isoforms against metabolic disorders and autoimmune diseases.
    [Show full text]
  • Resistin Levels and Inflammatory Markers in Patients with Morbid Obesity
    Nutr Hosp. 2010;25(4):630-634 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318 Original Resistin levels and inflammatory markers in patients with morbid obesity D. A. De Luis, M. González Sagrado, R. Conde, R. Aller and O. Izaola Instituto de Endocrinología y Nutrición Clínica. Medicine School and Unit of Investigation. Hospital Rio Hortega. RD-056/0013 RETICEF. University of Valladolid. Valladolid. Spain. Abstract NIVELES DE RESISTINA Y MARCADORES INFLAMATORIOS EN PACIENTES Background: The aim of the present study was to CON OBESIDAD MÓRBIDA explore the relationship of resistin levels with inflamma- tory markers and anthropometric parameters in morbid obese patients. Resumen Subjects: A population of 46 morbid obese was ana- lyzed. A complete nutritional and biochemical evaluation Introducción: El objetivo del presente estudio es eva- was performed. Patients were divided in two groups by luar la relación entre los niveles de resistina con los mar- median resistin value (3.49 ng/ml), group I (low values, cadores inflamatorios y parámetros antropométricos en average value 2.60 ± 0.5) and group II (high values, aver- pacientes obesos morbidos. age value 5.71 ± 2.25). Sujetos y métodos: Una muestra de 46 obesos morbidos Results: Patients in the group II had higher weight, fue analizada. Se realizó una valoración nutricional y bio- BMI, fat mass, waist circumference, LDL-cholesterol, química completa. Los pacientes fueron divididos en dos triglycerides, fibrinogen and C reactive protein than grupos en función de la mediana de resistina (3,49 ng/ml), patients in group I. In the multivariate analysis with age- grupo I (valores bajos, media del valor 2,60 ± 0,5 ng/ml) y and sex-adjusted basal resistin concentration as a depen- grupo II (valores altos, media del valor 5,71 ± 2,25 ng/ml).
    [Show full text]
  • Supporting Online Material
    1 2 3 4 5 6 7 Supplementary Information for 8 9 Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic 10 retinopathy 11 12 *Samuel A. Mills, *Andrew I. Jobling, *Michael A. Dixon, Bang V. Bui, Kirstan A. Vessey, Joanna A. Phipps, 13 Ursula Greferath, Gene Venables, Vickie H.Y. Wong, Connie H.Y. Wong, Zheng He, Flora Hui, James C. 14 Young, Josh Tonc, Elena Ivanova, Botir T. Sagdullaev, Erica L. Fletcher 15 * Joint first authors 16 17 Corresponding author: 18 Prof. Erica L. Fletcher. Department of Anatomy & Neuroscience. The University of Melbourne, Grattan St, 19 Parkville 3010, Victoria, Australia. 20 Email: [email protected] ; Tel: +61-3-8344-3218; Fax: +61-3-9347-5219 21 22 This PDF file includes: 23 24 Supplementary text 25 Figures S1 to S10 26 Tables S1 to S7 27 Legends for Movies S1 to S2 28 SI References 29 30 Other supplementary materials for this manuscript include the following: 31 32 Movies S1 to S2 33 34 35 36 1 1 Supplementary Information Text 2 Materials and Methods 3 Microglial process movement on retinal vessels 4 Dark agouti rats were anaesthetized, injected intraperitoneally with rhodamine B (Sigma-Aldrich) to label blood 5 vessels and retinal explants established as described in the main text. Retinal microglia were labelled with Iba-1 6 and imaging performed on an inverted confocal microscope (Leica SP5). Baseline images were taken for 10 7 minutes, followed by the addition of PBS (10 minutes) and then either fractalkine or fractalkine + candesartan 8 (10 minutes) using concentrations outlined in the main text.
    [Show full text]
  • Plasma Omentin Levels Are Inversely Associated with Atherosclerosis In
    Nishimura et al. Cardiovasc Diabetol (2019) 18:167 https://doi.org/10.1186/s12933-019-0973-3 Cardiovascular Diabetology ORIGINAL INVESTIGATION Open Access Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study Masami Nishimura1, Tomoaki Morioka1* , Mariko Hayashi1, Yoshinori Kakutani1, Yuko Yamazaki1, Masafumi Kurajoh1, Katsuhito Mori2, Shinya Fukumoto3, Atsushi Shioi4,5, Tetsuo Shoji4,5, Masaaki Inaba1,5 and Masanori Emoto1 Abstract Background: Omentin and adiponectin are among the anti-infammatory and anti-atherogenic adipokines that have potentially benefcial efects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings including type 2 diabetes. In this study, we characterized the clinical features of type 2 diabetes patients with increased adiponectin levels and exam- ined the association between omentin and atherosclerosis in those patients. Methods: The subjects were 413 patients with type 2 diabetes. Fasting plasma omentin and total adiponectin levels were measured by enzyme-linked immunosorbent assay. The intima-media thickness (IMT) of the common carotid artery was measured by ultrasonography. The subjects were stratifed according to the median value of plasma adiponectin. Results: In high-adiponectin group, omentin levels were higher, while IMT tended to be greater than those in low- adiponectin group. The high-adiponectin group also exhibited older age, higher systolic blood pressure, lower kidney function, body mass index, and insulin resistance index compared to the low-adiponectin group. Multivariate analysis revealed that omentin levels were independently and negatively associated with IMT in high-adiponectin group, but not in low-adiponectin group, after adjusting for adiponectin levels and traditional cardiovascular risk factors.
    [Show full text]
  • Resistin, Is There Any Role in the Mediation of Obesity, Insulin Resistance and Type-II Diabetes Mellitus?
    Review Article JOJ Case Stud Volume 6 Issue 3 - March 2018 Copyright © All rights are reserved by Rajeev Pandey DOI: 10.19080/JOJCS.2018.06.555686 Resistin, Is There any Role in the Mediation of Obesity, Insulin Resistance and Type-II Diabetes Mellitus? Rajeev Pandey1* and Gurumurthy2 1Department of Biochemistry, Spartan Health Science University, West Indies 2Department of Neurosciences, Spartan Health Science University, West Indies Submission: February 21, 2018; Published: March 05, 2018 *Corresponding author: Rajeev Pandey, Department of Biochemistry, Spartan Health Science University, St. Lucia, West Indies, Email: Abstract Resistin is a member of a class of cystein-rich proteins collectively termed as resistin-like molecules. Resistin has been implicated in tothe date pathogenesis there has ofbeen obesity-mediated considerable controversy insulin resistance surrounding and T2DM this 12.5kDa(Type II polypeptidediabetes mellitus). in understanding In addition, its resistin physiological also appears relevance to be in a bothpro- inflammatory cytokine. Taken together, resistin, like many other adipocytokines, may possess a dual role in contributing to disease risk. However, involvementhuman and rodent of resistin systems. molecule Furthermore, in the causation this has and led progression question, ofwhether obesity resistin and type represents II diabetes an mellitus important and pathogenicfactors associated factor within the alteration etiology inof theT2DM expression or not. Inof this magicreview, molecule authors athave physiological made an attemptand genetic to discuss levels. the key controversies and developments made so far towards the Keywords: Resistin; Obesity; T2DM; Insulin resistance Introduction Adipose tissue is known to produce a vast array of In addition, we will highlight the continuing complexity of the adipocyte-derived factors, known as adipocytokines.
    [Show full text]
  • Pathophysiology of Gestational Diabetes Mellitus: the Past, the Present and the Future
    6 Pathophysiology of Gestational Diabetes Mellitus: The Past, the Present and the Future Mohammed Chyad Al-Noaemi1 and Mohammed Helmy Faris Shalayel2 1Al-Yarmouk College, Khartoum, 2National College for Medical and Technical Studies, Khartoum, Sudan 1. Introduction It is just to remember that “Pathophysiology” refers to the study of alterations in normal body function (physiology and biochemistry) which result in disease. E.g. changes in the normal thyroid hormone level causes either hyper or hypothyroidism. Changes in insulin level as a decrease in its blood level or a decrease in its action will cause hyperglycemia and finally diabetes mellitus. Scientists agreed that gestational diabetes mellitus (GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy. From our experience most women with GDM in the developing countries are not aware of the symptoms (i.e., the disease will be symptomless). While some of the women will have few symptoms and their GDM is most commonly diagnosed by routine blood examinations during pregnancy which detect inappropriate high level of glucose in their blood samples. GDM should be confirmed by doing fasting blood glucose and oral glucose tolerance test (OGTT), according to the WHO diagnostic criteria for diabetes. A decrease in insulin sensitivity (i.e. an increase in insulin resistance) is normally seen during pregnancy to spare the glucose for the fetus. This is attributed to the effects of placental hormones. In a few women the physiological changes during pregnancy result in impaired glucose tolerance which might develop diabetes mellitus (GDM). The prevalence of GDM ranges from 1% to 14% of all pregnancies depending on the population studied and the diagnostic tests used.
    [Show full text]
  • NIH Public Access Author Manuscript Rev Endocr Metab Disord
    NIH Public Access Author Manuscript Rev Endocr Metab Disord. Author manuscript; available in PMC 2014 September 03. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Rev Endocr Metab Disord. 2014 June ; 15(2): 137–147. doi:10.1007/s11154-013-9280-6. ADIPONECTIN SIGNALING IN THE LIVER Terry P. Combs1,2,3 and Errol B. Marliss2 1Department of Medicine, University of North Carolina at Chapel Hill 2Crabtree Nutrition Laboratories, Department of Medicine, McGill University Abstract High glucose production contributes to fed and fasted hyperglycemia in Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D). The breakdown of the adiponectin signaling pathway in T1D and the reduction of circulating adiponectin in T2D contribute to this abnormal increase in glucose production. Sufficient amounts of insulin could compensate for the loss of adiponectin signaling in T1D and T2D and reduce hyperglycemia. However, the combination of low adiponectin signaling and high insulin resembles an insulin resistance state associated with cardiovascular disease and decreased life expectancy. Future development of medications that correct the deficiency of adiponectin signaling in the liver could restore the metabolic balance in T1D and T2D and reduce the need for insulin. This article reviews the adiponectin signaling pathway in the liver through T- cadherin, AdipoR1, AdipoR2, AMPK, ceramidase activity, APPL1 and the recently discovered Suppressor Of Glucose from Autophagy (SOGA). 1. Liver contribution to circulating glucose The liver releases glucose ensuring sufficient amounts of this essential fuel are always available in the circulation for other tissues. Endocrine and neural mechanisms stimulate the liver during fasting, exercise and pregnancy to meet the increased demand for glucose.
    [Show full text]
  • Metabolic Syndrome: Is It Time to Add the Central Nervous System?
    nutrients Review Metabolic Syndrome: Is It Time to Add the Central Nervous System? Milagros Rojas 1, Mervin Chávez-Castillo 2, Daniela Pirela 1, Heliana Parra 1 , Manuel Nava 1, Maricarmen Chacín 3, Lissé Angarita 4 , Roberto Añez 5, Juan Salazar 1 , Rina Ortiz 6, Samuel Durán Agüero 7, Marbel Gravini-Donado 8, Valmore Bermúdez 9 and Edgar Díaz-Camargo 9,* 1 Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4004, Venezuela; migarocafi@gmail.com (M.R.); [email protected] (D.P.); [email protected] (H.P.); [email protected] (M.N.); [email protected] (J.S.) 2 Psychiatric Hospital of Maracaibo, Maracaibo 4004, Venezuela; [email protected] 3 Facultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla 08002, Colombia; [email protected] 4 Escuela de Nutrición y Dietética, Facultad de Medicina, Universidad Andrés Bello, Sede Concepción 4260000, Chile; [email protected] 5 Departamento de Endocrinología y Nutrición, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain; [email protected] 6 Posgrado, Carrera de Medicina, Universidad Católica de Cuenca, Cantón de Cuenca 010101, Ecuador; [email protected] 7 Facultad de Ciencias Para el Cuidado de la Salud, Universidad San Sebastián, Los Leones 8420524, Chile; [email protected] 8 Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla 080002, Colombia; [email protected] 9 Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Cúcuta 540006, Colombia; [email protected] * Correspondence: [email protected] Citation: Rojas, M.; Chávez-Castillo, M.; Pirela, D.; Parra, H.; Nava, M.; Abstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central Chacín, M.; Angarita, L.; Añez, R.; obesity, hyperglycemia, hypertension, and dyslipidemias.
    [Show full text]
  • Links Between HPA Axis and Adipokines: Clinical Implications in Paradigms of Stress-Related Disorders
    Expert Review of Endocrinology & Metabolism ISSN: 1744-6651 (Print) 1744-8417 (Online) Journal homepage: https://www.tandfonline.com/loi/iere20 Links between HPA axis and adipokines: clinical implications in paradigms of stress-related disorders Panagiota Papargyri, Evangelia Zapanti, Nicolaos Salakos, Loukas Papargyris, Alexandra Bargiota & George MASTORAKOS To cite this article: Panagiota Papargyri, Evangelia Zapanti, Nicolaos Salakos, Loukas Papargyris, Alexandra Bargiota & George MASTORAKOS (2018) Links between HPA axis and adipokines: clinical implications in paradigms of stress-related disorders, Expert Review of Endocrinology & Metabolism, 13:6, 317-332, DOI: 10.1080/17446651.2018.1543585 To link to this article: https://doi.org/10.1080/17446651.2018.1543585 Accepted author version posted online: 01 Nov 2018. Published online: 13 Nov 2018. Submit your article to this journal Article views: 55 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=iere20 EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM 2018, VOL. 13, NO. 6, 317–332 https://doi.org/10.1080/17446651.2018.1543585 REVIEW Links between HPA axis and adipokines: clinical implications in paradigms of stress-related disorders Panagiota Papargyria, Evangelia Zapantib, Nicolaos Salakosc, Loukas Papargyrisd,e, Alexandra Bargiotaf and George MASTORAKOSa aUnit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion Hospital, School of Medicine, National and Kapodistrian
    [Show full text]
  • ADIPOQ) and the Type 1 Receptor (ADIPOR1), Obesity and Prostate Cancer in African Americans
    Prostate Cancer and Prostatic Diseases (2010) 13, 362–368 & 2010 Macmillan Publishers Limited All rights reserved 1365-7852/10 www.nature.com/pcan ORIGINAL ARTICLE Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans JL Beebe-Dimmer1, KA Zuhlke2, AM Ray2, EM Lange3 and KA Cooney4 1Department of Population Studies and Prevention, Karmanos Cancer Institute, Department of Internal Medicine, Wayne State University, Detroit, MI, USA; 2Departments of Internal Medicine and Urology, University of Michigan Medical School, Ann Arbor, MI, USA; 3Departments of Genetics and Biostatistics, University of North Carolina, Chapel Hill, NC, USA and 4Departments of Internal Medicine and Urology, University of Michigan Medical School, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA Adiponectin is a protein derived from adipose tissue suspected to have an important role in prostate carcinogenesis. Variants in the adiponectin gene (ADIPOQ) and its type 1 receptor (ADIPOR1) have been recently linked to risk of both breast and colorectal cancer. Therefore, we set out to examine the relationship between polymorphisms in these genes, obesity and prostate cancer in study of African-American men. Ten single-nucleotide polymorphisms (SNPs) in ADIPOQ and ADIPOR1 were genotyped in DNA samples from 131 African-American prostate cancer cases and 344 controls participating in the Flint Men’s Health Study. Logistic regression was then used to estimate their association with prostate cancer and obesity. While no significant associations were detected between any of the tested SNPs and prostate cancer, the rs1501299 SNP in ADIPOQ was significantly associated with body mass (P ¼ 0.03).
    [Show full text]
  • Quantigene Flowrna Probe Sets Currently Available
    QuantiGene FlowRNA Probe Sets Currently Available Accession No. Species Symbol Gene Name Catalog No. NM_003452 Human ZNF189 zinc finger protein 189 VA1-10009 NM_000057 Human BLM Bloom syndrome VA1-10010 NM_005269 Human GLI glioma-associated oncogene homolog (zinc finger protein) VA1-10011 NM_002614 Human PDZK1 PDZ domain containing 1 VA1-10015 NM_003225 Human TFF1 Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) VA1-10016 NM_002276 Human KRT19 keratin 19 VA1-10022 NM_002659 Human PLAUR plasminogen activator, urokinase receptor VA1-10025 NM_017669 Human ERCC6L excision repair cross-complementing rodent repair deficiency, complementation group 6-like VA1-10029 NM_017699 Human SIDT1 SID1 transmembrane family, member 1 VA1-10032 NM_000077 Human CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) VA1-10040 NM_003150 Human STAT3 signal transducer and activator of transcripton 3 (acute-phase response factor) VA1-10046 NM_004707 Human ATG12 ATG12 autophagy related 12 homolog (S. cerevisiae) VA1-10047 NM_000737 Human CGB chorionic gonadotropin, beta polypeptide VA1-10048 NM_001017420 Human ESCO2 establishment of cohesion 1 homolog 2 (S. cerevisiae) VA1-10050 NM_197978 Human HEMGN hemogen VA1-10051 NM_001738 Human CA1 Carbonic anhydrase I VA1-10052 NM_000184 Human HBG2 Hemoglobin, gamma G VA1-10053 NM_005330 Human HBE1 Hemoglobin, epsilon 1 VA1-10054 NR_003367 Human PVT1 Pvt1 oncogene homolog (mouse) VA1-10061 NM_000454 Human SOD1 Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]